Therapeutic Drug Monitoring of Atypical Antipsychotics: Is It of Potential Clinical Value?

ISSN： 1172-7047

Source： CNS Drugs, Vol.13, Iss.3, 2000-03, pp. : 167-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions

Current Medicinal Chemistry, Vol. 11, Iss. 3, 2004-02 ,pp. : 279-296

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Atypical Antipsychotics: Metabolism and Therapeutic Drug Monitoring (TDM)

Current Drug Metabolism, Vol. 16, Iss. 2, 2015-01 ,pp. : 141-151

Bentham Science Publishers

Access to resources Recommend Favorite

Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?

By Perucca E.

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 191-204

Adis International

Access to resources Recommend Favorite

Pharmacogenetics: The Therapeutic Drug Monitoring of the Future?

By Ensom M.H.H.

Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. : 783-802

Adis International

Access to resources Recommend Favorite

Atypical Antipsychotics for Neuropsychiatric Symptoms of Dementia: Malignant or Maligned?

By Herrmann Nathan Lanctôt Krista L.

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 833-843

Adis International

Access to resources Recommend Favorite